Drug Type Small molecule drug |
Synonyms [N-(N',N'-dimethylaminoethyl)-1,8-naphthalimide-4-sulfide](triethylphosphine)gold(I), gold(I)(Freie Universität Berlin) |
Target |
Action inhibitors |
Mechanism TrxR inhibitors(Thioredoxin reductase inhibitors), Angiogenesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30AuN2O2PS |
InChIKeyDKUOJCXAIZKHCJ-UHFFFAOYSA-N |
CAS Registry1110641-55-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Germany | 12 Feb 2009 |